How it works
Without that approval, the plan does not cover the prescription. A related tool is the formulary, the list of prescription drugs a plan covers, also called a drug list.1,3 Criteria differ from plan to plan. A 2026 study of Medicaid notes that earlier research found wide variation in prior authorization criteria between states.4
What the numbers show in Medicaid
KFF counted 16 state Medicaid programs covering GLP-1s for obesity treatment in October 2025. North Carolina dropped coverage that month because of a budget stalemate and restored it in December, and by January 2026 the count was 13, counting coverage under fee-for-service.2
The 2026 study followed all 51 programs, the 50 states and the District of Columbia. 17 covered at least one GLP-1 for obesity at some point in the study period, and 34 never covered these drugs. 5 withdrew coverage: North Carolina in October 2025, before reinstating it on December 12, and California, New Hampshire, Pennsylvania and South Carolina on January 1, 2026. Twelve kept coverage through the first quarter of 2026, including Massachusetts, whose withdrawal took effect in July 2026. Even where coverage existed, earlier studies had found use below 5% of eligible people.4 When coverage was withdrawn, the effect was large:4
- Dispensing fell by 84.7% for obesity in the withdrawing states compared with states that kept coverage, or 29.1 fewer prescriptions per 1,000 enrollees per quarter.
- No earlier gap. In the quarters before the withdrawals were announced, dispensing trends in the two groups of states did not differ clearly.
- The five states mattered. In 2025 they had 18.4 million of 70.5 million Medicaid enrollees, 26.1%, but 65.2% of the 3,725,732 obesity prescriptions for GLP-1s that Medicaid paid for.
- The sources. The authors built their timeline from state bulletins, preferred drug lists, prior authorization criteria and provider notices.
Why obesity coverage is optional
State Medicaid programs must cover nearly all FDA-approved drugs, but a long-standing exception in the law lets states choose whether to cover weight-loss drugs; KFF describes it as a statutory exception, written into the law itself. So GLP-1s for obesity are optional for states. Coverage is required for the approved uses in diabetes, in heart disease for Wegovy since March 2024, and in moderate to severe obstructive sleep apnea with obesity for Zepbound since December 2024.2
Cost is the pressure behind the controls. KFF reports that Medicaid's gross spending on GLP-1s rose ninefold, from about $1 billion in 2019 to almost $9 billion in 2024, with gross spending per prescription reaching $1,000 in 2024. It expects coverage to keep changing as states respond to budget challenges, to federal Medicaid spending cuts in the 2025 reconciliation law, and to a new federal model called BALANCE.2
In Medicare
Medicare.gov describes Medicare GLP-1 Bridge, which gives access to certain GLP-1 drugs for weight loss to people with Part D drug coverage who are not already getting them covered by Part D and who meet other requirements. Those who qualify pay $50 for a one-month supply.5
In practice
When a plan will not pay, the makers sell self-pay versions of the approved drugs; our page on GLP-1 costs without insurance compares them.
Sources
- HealthCare.gov. Prior authorization. Glossary, Centers for Medicare & Medicaid Services, read November 20, 2026. healthcare.gov
- Williams E. Medicaid coverage of and spending on GLP-1s. KFF, January 16, 2026. kff.org
- HealthCare.gov. Formulary. Glossary, Centers for Medicare & Medicaid Services, read November 20, 2026. healthcare.gov
- Nyambod FT, Msemakweli JG, Onesphore M, et al. Medicaid coverage withdrawal and dispensing of glucagon-like peptide-1 receptor agonists for obesity. Cureus 2026;18:e119224. doi:10.7759/cureus.119224
- Medicare.gov. Obesity behavioral therapy. Centers for Medicare & Medicaid Services, read November 20, 2026. medicare.gov
Related analyses
GLP-1 cost without insurance: every manufacturer self-pay price, dose by dose
Wegovy cost: what the pen and the pill cost with insurance, without it, and over a year
Zepbound cost: what you pay with insurance, without it, and over a year
Compounded semaglutide and tirzepatide in 2026: what FDA allows, what it has reported, and what to check
Log your weight and BMI over time, so the history is ready if your plan asks for it.
Open Dose Insider